GPT and metabolic dysfunction-associated steatotic liver disease: With a lower value of 0.18 and a higher value of 0.48, the patients were divided into three groups with different prevalence risk of hepatic steatosis, facilitating clinicians assess the risk of NAFLD and distinct that whether elevated ALT level was caused by NAFLD.